Mandelshtam M, Chakir K, Shevtsov S, Golubkov V, Skobeleva N, Lipovetsky B, Konstantinov V, Denisenko A, Gaitskhoki V, Schwartz E
Institute for Experimental Medicine, St. Petersburg, Russia.
Hum Mutat. 1998;12(4):255-8. doi: 10.1002/(SICI)1098-1004(1998)12:4<255::AID-HUMU6>3.0.CO;2-E.
We used polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis to detect LDL receptor gene defects in the St. Petersburg population. We have found a deltaG197 mutation in several patients of Jewish origin. The mutation named is shown to be responsible for one-third (7/23) of familial hypercholesterolemia (FH) cases in St. Petersburg Jews and absent in patients of Russian descent. The prevalence of a deltaG197 mutation in St. Petersburg Jews is consistent with its origin in Lithuania or Poland. The deltaG197 mutation can be easily detected in polyacrylamide minigels because of formation of specific heteroduplexes during PCR with DNA of heterozygous patients. Taken together with high prevalence of the mutation in St. Petersburg Jews, this observation provides an opportunity for DNA diagnostics of FH in this ethnic group.
我们采用聚合酶链反应-单链构象多态性(PCR-SSCP)分析来检测圣彼得堡人群中的低密度脂蛋白受体基因缺陷。我们在几名犹太裔患者中发现了ΔG197突变。已表明该命名突变导致圣彼得堡犹太人中三分之一(7/23)的家族性高胆固醇血症(FH)病例,而在俄罗斯裔患者中不存在。圣彼得堡犹太人中ΔG197突变的患病率与其起源于立陶宛或波兰一致。由于在与杂合子患者的DNA进行PCR过程中形成了特定的异源双链体,ΔG197突变可以很容易地在聚丙烯酰胺微型凝胶中检测到。结合该突变在圣彼得堡犹太人中的高患病率,这一观察结果为该族群中FH的DNA诊断提供了机会。